[heckel NEWS LETTER] 2020년 10월호

관리자 2020.10.15 조회 124
1) wIRA Oberflächenhyperthermie mit hydrosun®-TWH1500 im Journal of Clinical Oncology
In May 2020 Buchholz, Ali und Hunt (MD Anderson Cancer Centers San Diego and Houston) published a review on "Multidisciplinary Management of Locoregional Recurrent Breast Cancer" in the Journal of Clinical Oncology.

In a Correspondence published in September 2020, Thomsen, Vaupel, Grosu from University Medical Center Freiburg, and Notter from Lindenhofspital Bern presented thermograpy-controlled wIRA superficial hyperthermia combined with hypofractionated re-irradiation as an effective therapeutic option especially for large-sized lesions. They emphasized that combined hyperthermia/radiotherapy could not only be applied in patients without metastasis but - in a palliative approach - generally in all irresectable local recurrences of breast cancer in pre-irradiated areas.

In a simultaneously published reply, Buchholz et al. "commend Notter et al. for publishing their experience of treating 201 patients with locally recurrent breast cancer by using a modern hyperthermia technology that allowed for large-field hyperthermia combined with low-dose re-irradiation. They report excellent rates of tumor response, local control, and locally progressive free survival. We agree with Notter et al. that a confirmatory phase III comparative trial is not feasible, and therefore we find their recent publication to add to options for therapeutic consideration".

Correspondence and Reply are freely accessible:

- Thomsen AR, Vaupel P, Grosu AL, Notter M: Hyperthermia Plus Re-Irradiation in the Management of Unresectable Locoregional Recurrence of Breast Cancer in Previously Irradiated Sites. J Clin Oncol. 2020 Sep 8;JCO2001857. doi: 10.1200/JCO.20.01857
 
- Buchholz TA, Ali S, Hunt KK: Reply to Thomsen A. et al. J Clin Oncol.  2020 Sep 8;JCO2002247. doi: 10.1200/JCO.20.02247

 
2) ICHO 2021 vom 06.-09. Oktober 2021 in Rotterdam
Postponed from 2020, the 13th International Congress of Hyperthermic Oncology (ICHO) takes place from 6. - 9. Oktober 2021 in Rotterdam.The congress homepage is https://www.icho2021.eu/

The ICHO congress is organized every four years and is the combined international meeting of the Asian Society of Hyperthermic Oncology (ASHO), the American Society of Thermal Medicine (STM) and the European Society for Hyperthermic Oncology (ESHO).

heckel is a sponsor of the congress and is present with a booth in the industrial exhibition.
 
본 게시물은 독일 heckel gmbH.에서 발행한 뉴스레터의 내용입니다.
원본 보기> heckelNews October 2020